Project Details
Description
A phase 3 open label, randomized, multicenter study of NKTR-102 versus treatment of physician's choice (TPC) in patients with metastatic breast cancer who have stable brain metastases and have been
| Status | Finished |
|---|---|
| Effective start/end date | 11/1/16 → 11/30/22 |
Funding
- NEKTAR THERAPEUTICS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.